Combating cancer immunotherapy resistance: a nano‐medicine perspective
Abstract Cancer immunotherapy offers renewed hope for treating this disease. However, cancer cells possess inherent mechanisms that enable them to circumvent each stage of the immune cycle, thereby evading anti‐cancer immunity and leading to resistance.
Xiangyi Kong+10 more
wiley +1 more source
Side Effects of Immunosuppressant Drugs After Liver Transplant. [PDF]
Gabrielli F+6 more
europepmc +1 more source
Clinical Outcomes of Hospitalized Immunocompromised Patients With COVID-19 and the Impact of Hyperinflammation: A Retrospective Cohort Study. [PDF]
Zhang X+11 more
europepmc +1 more source
Monkeypox infection in kidney transplant recipients. [PDF]
Suliman O+3 more
europepmc +1 more source
Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck. [PDF]
Iancu D+11 more
europepmc +1 more source
IMMUNOSUPPRESSION WITH AZATHIOPRINE, PREDNISONE, AND CYCLOPHOSPHAMIDE1
John Jeffery+3 more
openalex +1 more source
Chlorogenic Acid: An In‐Depth Review of Its Effectiveness in Cancer Treatment
ABSTRACT Cancer remains a formidable global health challenge. Owing to the unsatisfactory curative effects and severe side effects, it is urgent to explore safer and more effective therapeutic alternatives and drugs. Chlorogenic acid (CGA), a natural polyphenol, has emerged as a promising candidate for cancer therapy due to its multiple functions and ...
Bin Wang+9 more
wiley +1 more source
Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou+6 more
wiley +1 more source
Providing care for kidney transplant recipients: An overview for generalists. [PDF]
Belal AA+3 more
europepmc +1 more source